Oscar Health Inc is trading 4.1% up at $28.98 following a bullish analyst upgrade and broader market momentum.
- Barclays upgraded the stock to Overweight with a raised price target of $35, citing significant growth potential for the company.
- The move extends a sharp rally for the stock this week, further supported by general strength in U.S. equity markets today.